Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia Advani, Anjali S. , Larsen, Eric , Laumann, Kristina ... - - Blood Adv - 2021 Manuscript - Secondary - Primary - Leukemia - CALGB-10403 , COG-AALL0232
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance) Byrd, John C. , Ruppert, Amy S. , Heerema, Nyla A. ... - - Blood Adv - 2018 Manuscript - Primary - Primary - Leukemia - CALGB-10404
Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801 Marcucci, Guido , Geyer, Susan , Laumann, Kristina , Zhao, Weiqiang ... - - Blood Adv - 2020 Manuscript - Primary - Primary - Leukemia - CALGB-10801 , CALGB-20202
Clinical and functional significance of circular RNAs in cytogenetically normal AML Papaioannou, Dimitrios , Volinia, Stefano , Nicolet, Deedra ... - - Blood Adv - 2020 Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C8721 , C8821 , C9022 , CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-8525 , CALGB-9022 , CALGB-9120 , CALGB-9222
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance) Roboz, Gail J. , Mandrekar, Sumithra J. , Desai, Pinkal ... - - Blood Adv - 2018 Manuscript - Primary - Primary - Leukemia - CALGB-11002
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001 Uy, Geoffrey L. , Mandrekar, Sumithra J. , Laumann, Kristina ... - - Blood Adv - 2017 Manuscript - Primary - Primary - Leukemia - CALGB-11001
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission Vasu, Sumithira , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Blood Adv - 2018 Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - C8221 , C8461 , C8525 , C8721 , C8821 , C9022 , C9720 , CALGB-19808 , CALGB-8923 , CALGB-9222 , CALGB-9420 , CALGB-9621 , CALGB-9720
Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN Voorhees, Peter M. , Rodriguez, Cesar , Reeves, Brandi ... - - Blood Adv - 2021 Manuscript - Secondary - Long-Term-Followup - Myeloma - AFT-29
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial Voso, Maria Teresa , Larson, Richard A. , Jones, Dan ... - - Blood Adv - 2020 Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-10603
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614) Yin, Jun , LaPlant, Betsy , Uy, Geoffrey L. , Marcucci, Guido ... - - Blood Adv - 2019 Manuscript - Primary - Primary - Leukemia - A151614 , CALGB-10201 , CALGB-10503 , CALGB-10603 , CALGB-10801 , CALGB-11001
